According to Alembic Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $0.72 B. In 2022 the company made a revenue of $0.70 B an increase over the years 2021 revenue that were of $0.68 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.72 B | 3.06% |
2022 | $0.70 B | 2.74% |
2021 | $0.68 B | -2.51% |
2020 | $0.69 B | 16.87% |
2019 | $0.59 B | 7.19% |
2018 | $0.55 B | 19.54% |
2017 | $0.46 B | 4.1% |
2016 | $0.44 B | -1.59% |
2015 | $0.45 B | 41.29% |
2014 | $0.32 B | 10.57% |
2013 | $0.29 B |